Pasithea Therapeutics Corp.

KTTA · NASDAQ
Analyze with AI
$1.26+$0.1344 (+11.89%)
At close:Dec 15, 2025, 7:25 PM UTC
$1.26−$0.0094 (−0.74%)
After hours:Dec 15, 2025, 7:24 PM UTC
P/E TTM-0
P/B TTM0
P/S TTM14.5
Dividend Yield0%
EPS-$4.43
Beta0.214
Valuation
PEG Ratio-0.00
FCF Yield-104,327.94%
EV / EBITDA1.32
Quality
ROIC-25.47%
Gross Margin0.16%
Cash Conv. Ratio0.95
Growth
Revenue 3Y CAGR
FCF Growth-108,266.81%
Safety
Net Debt / EBITDA1.32
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Pasithea Therapeutics Corp. (KTTA) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Pasithea Therapeutics Corp. (KTTA) stock price today?

As of Dec 15, 2025, 7:25 PM UTC, Pasithea Therapeutics Corp. (KTTA) stock is trading at $1.26. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date KTTA stock quotes for informed trading decisions.

What is Pasithea Therapeutics Corp.'s market capitalization?

Pasithea Therapeutics Corp. (KTTA) has a market capitalization of approximately $9.4M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Pasithea Therapeutics Corp.'s size relative to other companies in the USD market. The market cap figure updates automatically as the KTTA stock price changes.

What is the 52-week range for Pasithea Therapeutics Corp. stock?

Pasithea Therapeutics Corp. (KTTA) stock has traded in a 52-week range of $0.281 — $3.85. The 52-week range shows the highest and lowest prices at which KTTA traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Pasithea Therapeutics Corp. stock price to this range provides context for recent price action.

How much trading volume does Pasithea Therapeutics Corp. stock have?

Pasithea Therapeutics Corp. (KTTA) stock recently traded approximately 876.1K shares. Trading volume indicates market liquidity and investor interest in KTTA. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Pasithea Therapeutics Corp. stock.

Does Pasithea Therapeutics Corp. pay dividends to shareholders?

Yes, Pasithea Therapeutics Corp. (KTTA) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Pasithea Therapeutics Corp. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Pasithea Therapeutics Corp.'s intraday price range?

Today, Pasithea Therapeutics Corp. (KTTA) stock has traded in a range of $1.11 — $1.28. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring KTTA's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Pasithea Therapeutics Corp. stock data?

AlphaPilot sources real-time KTTA stock quotes, fundamental financial data, and historical price charts for Pasithea Therapeutics Corp. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Pasithea Therapeutics Corp. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of KTTA stock performance.